| Description | IgA | Package insert | IgG | Package insert | IgM | Package insert | General information | Remarks |
| Aeskulisa Diagnostic GmbH α2-Glyco |
Method: EIA Assay principle: Two step Coating: Native human α2-glycoprotein I Entity: Qualitative and quantitative |
|||||||
| Affinity Biologicals |  |
Affinity Biologicals | Method: EIA/ ELISA
Assay principle: Two step |
|||||
| AIDA α2 GP1 |
Method: EIA Assay principle: Two step Coating: Native human α2-glycoprotein I Entity: Qualitative and quantitative |
|||||||
| American Diagnostica LAPL-ELISA |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Semi-quantitative |
|||||||
| American Diagnostica IMUCLONE anti-α2GPI |
Method: EIA Assay principle: Two step Coating: Purified native uncleaved α2-glycoprotein I Entity: Quantitative |
|||||||
| Biomedical Diagnostics Anti-α2GPI EIA kit | Method: EIA | |||||||
| Biomedical Diagnostics Human Anti-α2GPI Sapporo EIA kit | Method: EIA | |||||||
| Bio-Rad Anti-Beta 2 Glycoproteine I | Method: EIA
Entity: Semi quantitative |
|||||||
| Bio-Rad BioPlex APLS | Method: A simultaneous detection of two auto antibodies (anti-Cardiolipin and anti-Beta-2 Glycoprotein I) | |||||||
| BL Diagnostika Anti-beta-2-Glycoprotein | ||||||||
| BMD Cardiolisa α2-GPI LISA |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Qualitative or quantitative |
|||||||
| BMD FIDIS | Method: Flow
Assay principle: A panel to detect autoantibodies to Cardiolipin, Beta 2 Glycoprotein and ProthrombinEntity: Semi-quantitative |
|||||||
| Cambridge Life Sciences |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I |
|||||||
| Corgenix Reaads Anti-Beta 2 Glycoprotein I |
Method: EIA Assay principle: Two step Coating: Human α2-glycoprotein I Entity: Semi-quantitative |
|||||||
| Diagnostica Stago Asserachrom Anti-α2GP1 |
Method: EIA Assay principle: Two step Coating: Human α2-glycoprotein I Entity: Semi-quantitative |
|||||||
| Dialab Anti-Beta-2-Glycoprotein |
Method: EIA Assay principle: Two step Entity: Quantitative |
|||||||
| Diamedix ls anti-B2-Glycoprotein |
Method: EIA Assay principle: two step Coating: Purified human α2-glycoprotein I Entity: Semi-quantitative |
|||||||
| DiaSorin Inc. ETI-Beta2 Glycoprotein I | Method: EIAEntity: Quantitative | |||||||
| Euro Diagnostica Anti-beta-2-glycoprotein 1 DIASTAT |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Qualitative and quantitative |
|||||||
| Euroimmun α2-glycoprotein 1 | Method: EIA
Coating: Purified native, human serum |
|||||||
| Fenning BioMed α2 Glycoprotein 1 | Method: EIA | |||||||
| Generic Assays |
Method: EIA Assay principle: Two step Coating: Human α2-glycoprotein I Entity: Semi-quantitative or quantitative |
|||||||
| Genesis Diagnostics Anti-α2 GP I |
Method: EIA Assay principle: Two step Coating: Human α2-glycoprotein I Entity: IgA and IgM are semi-quantitative. IgG is quantitative/ semi-quantitative |
|||||||
| Haemochrom Anti-Beta 2 Glycoprotein 1 Test Kit |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Semi-quantitative |
|||||||
| Hycor Biomedical Anti-α2-Glycoprotein-I | ||||||||
| Hyphen BioMed ZYMUTEST Anti-B2GPI | |
|
|
Hyphen Biomed |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein Entity: Quantitative |
|||
| IBL Anti-α2-Glycoprotein 1 |
Method: EIA Assay principle: Two step Coating: Human α2-glycoprotein I Entity: Qualitative or quantitative |
|||||||
| Imtec GmbH IMTEC α2-Glycoprotein I-Antibodies | Method: EIAEntity: Quantitative | |||||||
| INOVA Diagnostics QUANTA Flash B2 GPI |
Method: CIA Entity: Semi-quantitative |
|||||||
| INOVA Diagnostics Inc. QUANTA Lite B2 GPI |
Method: EIA Assay principle: Two step Coating: Purifiedα2-glycoprotein I Entity: Semi-quantitative |
|||||||
| Instrumentation Laboratory AcuStar Anti-B2 GPI | |
|
Instrumentation Laboratory AcuStar Anti-B2 GPI |
Method: EIA (chemiluminescent) Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Semi-quantitative |
||||
| Orgentec (Alegria) Anti-Beta-2-Glycoproteine I |
Method: EIA Assay principle: two step Coating: α2-glycoprotein I Entity: Quantitative |
|||||||
| Orgentec (Elisa) Anti-Beta-2-Glycoprotein I |
Method: EIA Assay principle: Two step Coating: Purified α2-glycoprotein I Entity: Quantitative |
|||||||
| Thermo Scientific EliA α2-Glycoprotein |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Quantitative |
|||||||
| Thermo Scientific Varelisa α2-Glycoprotein I |
Method: EIA Assay principle: Two step Coating: Purified human α2-glycoprotein I Entity: Quantitative |
|||||||
| TheraTest EL-B2GPI |
Method: EIA Assay principle: Two step Coating: α2-glycoprotein I Entity: Quantitative |
|||||||
| TheraTest EL-B2GPI Screen |
Method: EIA Assay principle: Two step Coating: α2-glycoprotein I Entity: Qualitative/ semi-quantitative |
© Copyright - Ecat